Clinical Trial Update: A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis [Phase 1]

View source ↗

Summary

A phase 1 study of LY3844583 in healthy participants and individuals with atopic dermatitis was terminated; the document does not report study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• LY3844583

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy, Dermatitis, Atopic | Phase 1 | Status: TERMINATED